Starting April 21, you’ll be asked to log in or sign up for a free account after viewing 10 content pages each month.
Don’t worry—creating an account is quick and easy, and it comes with added benefits! Once logged in, you’ll not only continue accessing the content you already enjoy, but you’ll also unlock exclusive features like interactive donut plots for variant protein effects and variant impacts across the gene.
Stay tuned for these updates, and thank you for being part of our community!
Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | CTNNB1 |
Variant | S45del |
Impact List | deletion |
Protein Effect | gain of function |
Gene Variant Descriptions | CTNNB1 S45del results in the deletion of an amino acid at a Gsk3b phosphorylation site of the Ctnnb1 protein at amino acid 45 (PMID: 9065402). S45del confers a gain of function to the Ctnnb1 protein as demonstrated by stabilization and nuclear accumulation of Ctnnb1 (PMID: 9065402, PMID: 21084400). |
Associated Drug Resistance | |
Category Variants Paths |
CTNNB1 mutant CTNNB1 act mut CTNNB1 S45del |
Transcript | NM_001098210.2 |
gDNA | chr3:g.41224645_41224647delTCT |
cDNA | c.133_135delTCT |
Protein | p.S45delS |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_001330729.2 | chr3:g.41224666_41224668delCCT | c.133_135delCCT | p.P45delP | RefSeq | GRCh38/hg38 |
XM_017005738 | chr3:g.41224645_41224647delTCT | c.133_135delTCT | p.S45del | RefSeq | GRCh38/hg38 |
XM_047447482.1 | chr3:g.41224666_41224668delCCT | c.133_135delCCT | p.P45delP | RefSeq | GRCh38/hg38 |
XM_024453356.1 | chr3:g.41224645_41224647delTCT | c.133_135delTCT | p.S45del | RefSeq | GRCh38/hg38 |
XM_047447480.1 | chr3:g.41224645_41224647delTCT | c.133_135delTCT | p.S45delS | RefSeq | GRCh38/hg38 |
NM_001098209 | chr3:g.41224645_41224647delTCT | c.133_135delTCT | p.S45del | RefSeq | GRCh38/hg38 |
XM_047447477.1 | chr3:g.41224645_41224647delTCT | c.133_135delTCT | p.S45delS | RefSeq | GRCh38/hg38 |
XM_017005738.1 | chr3:g.41224645_41224647delTCT | c.133_135delTCT | p.S45del | RefSeq | GRCh38/hg38 |
NM_001098210.1 | chr3:g.41224645_41224647delTCT | c.133_135delTCT | p.S45del | RefSeq | GRCh38/hg38 |
NM_001904.3 | chr3:g.41224645_41224647delTCT | c.133_135delTCT | p.S45del | RefSeq | GRCh38/hg38 |
XM_005264886 | chr3:g.41224645_41224647delTCT | c.133_135delTCT | p.S45del | RefSeq | GRCh38/hg38 |
NM_001904 | chr3:g.41224645_41224647delTCT | c.133_135delTCT | p.S45del | RefSeq | GRCh38/hg38 |
NM_001098209.1 | chr3:g.41224645_41224647delTCT | c.133_135delTCT | p.S45del | RefSeq | GRCh38/hg38 |
XM_047447483.1 | chr3:g.41224645_41224647delTCT | c.133_135delTCT | p.S45delS | RefSeq | GRCh38/hg38 |
XM_006712985.1 | chr3:g.41224645_41224647delTCT | c.133_135delTCT | p.S45del | RefSeq | GRCh38/hg38 |
XM_024453357.1 | chr3:g.41224645_41224647delTCT | c.133_135delTCT | p.S45del | RefSeq | GRCh38/hg38 |
XM_024453356.2 | chr3:g.41224645_41224647delTCT | c.133_135delTCT | p.S45delS | RefSeq | GRCh38/hg38 |
NM_001904.4 | chr3:g.41224645_41224647delTCT | c.133_135delTCT | p.S45delS | RefSeq | GRCh38/hg38 |
NM_001098210.2 | chr3:g.41224645_41224647delTCT | c.133_135delTCT | p.S45delS | RefSeq | GRCh38/hg38 |
XM_047447479.1 | chr3:g.41224645_41224647delTCT | c.133_135delTCT | p.S45delS | RefSeq | GRCh38/hg38 |
NM_001098209.2 | chr3:g.41224645_41224647delTCT | c.133_135delTCT | p.S45delS | RefSeq | GRCh38/hg38 |
XM_047447481.1 | chr3:g.41224645_41224647delTCT | c.133_135delTCT | p.S45delS | RefSeq | GRCh38/hg38 |
XM_017005738.2 | chr3:g.41224645_41224647delTCT | c.133_135delTCT | p.S45delS | RefSeq | GRCh38/hg38 |
NM_001098210 | chr3:g.41224645_41224647delTCT | c.133_135delTCT | p.S45del | RefSeq | GRCh38/hg38 |
XM_006712985 | chr3:g.41224645_41224647delTCT | c.133_135delTCT | p.S45del | RefSeq | GRCh38/hg38 |
XM_006712985.2 | chr3:g.41224645_41224647delTCT | c.133_135delTCT | p.S45delS | RefSeq | GRCh38/hg38 |
XM_047447478.1 | chr3:g.41224645_41224647delTCT | c.133_135delTCT | p.S45delS | RefSeq | GRCh38/hg38 |
XM_024453358.1 | chr3:g.41224645_41224647delTCT | c.133_135delTCT | p.S45del | RefSeq | GRCh38/hg38 |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|---|---|---|---|---|---|---|
CTNNB1 S45del | colon carcinoma | predicted - sensitive | NTRC 0066-0 | Preclinical - Cell culture | Actionable | In a preclinical study, cell lines harboring CTNNB1 hotspot mutations, including a colon carcinoma cell line harboring CTNNB1 S45del, demonstrated increased sensitivity to NTRC 0066-0 compared to cell lines with wild-type CTNNB1 or an isogenic cell line lacking the CTNNB1 mutation, in culture (PMID: 28751540). | 28751540 |
CTNNB1 S45del | colon carcinoma | predicted - sensitive | Mps-BAY2b | Preclinical - Cell culture | Actionable | In a preclinical study, cell lines harboring CTNNB1 hotspot mutations, including a colon carcinoma cell line harboring CTNNB1 S45del, demonstrated increased sensitivity to Mps-BAY2b compared to cell lines with wild-type CTNNB1 in culture (PMID: 28751540). | 28751540 |
CTNNB1 S45del | colon carcinoma | predicted - sensitive | NMS-P715 | Preclinical - Cell culture | Actionable | In a preclinical study, cell lines harboring CTNNB1 hotspot mutations, including a colon carcinoma cell line harboring CTNNB1 S45del, demonstrated increased sensitivity to NMS-P715 compared to cell lines with wild-type CTNNB1 in culture (PMID: 28751540). | 28751540 |
CTNNB1 S45del | colon carcinoma | predicted - sensitive | BAY1161909 | Preclinical - Cell culture | Actionable | In a preclinical study, cell lines harboring CTNNB1 hotspot mutations, including a colon carcinoma cell line harboring CTNNB1 S45del, demonstrated increased sensitivity to BAY1161909 compared to cell lines with wild-type CTNNB1 in culture (PMID: 28751540). | 28751540 |
CTNNB1 S45del | colorectal adenocarcinoma | predicted - sensitive | BAY1161909 | Preclinical - Cell culture | Actionable | In a preclinical study, cell lines harboring CTNNB1 hotspot mutations, including a colorectal adenocarcinoma cell line harboring CTNNB1 S45del, demonstrated increased sensitivity to BAY1161909 compared to cell lines with wild-type CTNNB1 in culture (PMID: 28751540). | 28751540 |
CTNNB1 S45del | colon carcinoma | predicted - sensitive | BAY1217389 | Preclinical - Cell culture | Actionable | In a preclinical study, cell lines harboring CTNNB1 hotspot mutations, including a colon carcinoma cell line harboring CTNNB1 S45del, demonstrated increased sensitivity to BAY1217389 compared to cell lines with wild-type CTNNB1 in culture (PMID: 28751540). | 28751540 |
CTNNB1 S45del | colon carcinoma | predicted - sensitive | Mps1-IN-1 | Preclinical - Cell culture | Actionable | In a preclinical study, cell lines harboring CTNNB1 hotspot mutations, including a colon carcinoma cell line harboring CTNNB1 S45del, demonstrated increased sensitivity to Mps1-IN-1 compared to cell lines with wild-type CTNNB1 in culture (PMID: 28751540). | 28751540 |
CTNNB1 S45del | colon carcinoma | predicted - sensitive | MPI-0479605 | Preclinical - Cell culture | Actionable | In a preclinical study, cell lines harboring CTNNB1 hotspot mutations, including a colon carcinoma cell line harboring CTNNB1 S45del demonstrated increased sensitivity to MPI-0479605 compared to cell lines with wild-type CTNNB1 in culture (PMID: 28751540). | 28751540 |